Alessio Bruni

13PUBLICATIONS
67CO-AUTHORS
Radiation therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsInstruments and techniquesToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Feb 19, 2025
Impact of stereotactic body radiotherapy after progression in castrate resistant prostate cancer patients undergoing first line abiraterone treatment. A subgroup analysis from ARTO trial (NCT03449719).

Giulio Francolini, Niccolò Bertini, Vanessa Di Cataldo

|Nov 26, 2024
Current Radiotherapy Management of Extensive-Stage Small-Cell Lung Cancer in the Immunotherapy Era: An Italian National Survey on Behalf of the Italian Association of Radiotherapy and Clinical Oncology (AIRO).

Alessio Bruni, Vieri Scotti, Maria Alessia Zerella

|Jul 05, 2024
Management of oligometastatic and oligoprogressive epidermal growth factor receptor mutated non-small cell lung cancer patients: state of the art of a combined approach.

Francesca Di Pressa, Fabiana Perrone, Anna Benini

|Apr 06, 2024
Dose-intensified stereotactic body radiotherapy for painful vertebral metastases: A randomized phase 3 trial.

Matthias Guckenberger, Charlotte Billiet, Daniel Schnell

|Nov 25, 2023
PSMA PET/CT in Castration-Resistant Prostate Cancer: Myth or Reality?

Luca Urso, Luca Filippi, Angelo Castello

|Sep 21, 2023
Stereotactic Body Radiation Therapy and Abiraterone Acetate for Patients Affected by Oligometastatic Castrate-Resistant Prostate Cancer: A Randomized Phase II Trial (ARTO).

Giulio Francolini, Andrea Gaetano Allegra, Beatrice Detti

Pageof 3

Frequent Collaborators

3 joint publications

Gianluca Ingrosso

3 joint publications

Marcello Tiseo

3 joint publications

Stefano Maria Magrini

2 joint publications

Frank Lohr